Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
184,457
clinical trials

Gastroenterology Clinical Trial
A Safety Extension Study of SHP647 in Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)
Status: Enrolling, Phase III
Updated: 12/31/1969
Advanced Biomedical Research of America
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Gastroenterology Clinical Trial
A Safety Extension Study of SHP647 in Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)
Status: Enrolling, Phase III
Updated: 12/31/1969
Vanderbilt University Medical Center
mi
from
Nashville, TN
Click here to add this to my saved trials
Gastroenterology Clinical Trial
A Safety Extension Study of SHP647 in Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)
Status: Enrolling, Phase III
Updated: 12/31/1969
Univ of Washington
mi
from
Seattle, WA
Click here to add this to my saved trials
Gastroenterology Clinical Trial
A Safety Extension Study of SHP647 in Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)
Status: Enrolling, Phase III
Updated: 12/31/1969
Chevy Chase Clinical Research
mi
from
Chevy Chase, MD
Click here to add this to my saved trials
Gastroenterology Clinical Trial
A Safety Extension Study of SHP647 in Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)
Status: Enrolling, Phase III
Updated: 12/31/1969
Gastro One
mi
from
Germantown, TN
Click here to add this to my saved trials
Gastroenterology Clinical Trial
A Safety Extension Study of SHP647 in Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)
Status: Enrolling, Phase III
Updated: 12/31/1969
Nuren Medical & Research Center
mi
from
Miami, FL
Click here to add this to my saved trials
Gastroenterology Clinical Trial
A Safety Extension Study of SHP647 in Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)
Status: Enrolling, Phase III
Updated: 12/31/1969
Elite Clinical Studies
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Gastroenterology Clinical Trial
A Safety Extension Study of SHP647 in Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)
Status: Enrolling, Phase III
Updated: 12/31/1969
Inland Empire Liver Foundation
mi
from
Rialto, CA
Click here to add this to my saved trials
Endocrinology, Gastroenterology Clinical Trial
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis
Status: Enrolling, Phase III
Updated: 12/31/1969
University of Colorado Denver
mi
from
Aurora, CO
Click here to add this to my saved trials
Endocrinology, Gastroenterology Clinical Trial
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis
Status: Enrolling, Phase III
Updated: 12/31/1969
AGA Clinical Research Associates, LLC
mi
from
Egg Harbor Township, NJ
Click here to add this to my saved trials
Endocrinology, Gastroenterology Clinical Trial
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis
Status: Enrolling, Phase III
Updated: 12/31/1969
Montana Medical Research
mi
from
Missoula, MT
Click here to add this to my saved trials
Endocrinology, Gastroenterology Clinical Trial
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis
Status: Enrolling, Phase III
Updated: 12/31/1969
Quality Medical Research Pllc
mi
from
Nashville, TN
Click here to add this to my saved trials
Endocrinology, Gastroenterology Clinical Trial
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis
Status: Enrolling, Phase III
Updated: 12/31/1969
Southwest Gastroenterology
mi
from
Oak Lawn, IL
Click here to add this to my saved trials
Endocrinology, Gastroenterology Clinical Trial
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis
Status: Enrolling, Phase III
Updated: 12/31/1969
Northwest Gastroenterology Clinic, LLC
mi
from
Portland, OR
Click here to add this to my saved trials
Endocrinology, Gastroenterology Clinical Trial
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis
Status: Enrolling, Phase III
Updated: 12/31/1969
Troy Gastroenterology PC Center for Digestive Health
mi
from
Troy, MI
Click here to add this to my saved trials
Endocrinology, Gastroenterology Clinical Trial
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis
Status: Enrolling, Phase III
Updated: 12/31/1969
Trial Management Associates LLC
mi
from
Wilmington, NC
Click here to add this to my saved trials
Endocrinology, Gastroenterology Clinical Trial
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis
Status: Enrolling, Phase III
Updated: 12/31/1969
The Center for Clinical Research
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Oncology Clinical Trial
Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma
Status: Enrolling
Updated: 2/6/2018
Fox Chase Cancer Center - Philadelphia
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Musculoskeletal Clinical Trial
Inpatient Multimodal Path to RecOVEry
Status: Enrolling
Updated: 10/2/2017
Carolinas HealthCare System Union
mi
from
Monroe, NC
Click here to add this to my saved trials
Severe Aplastic Anemia Clinical Trial
Unrelated Donor Transplant Versus Immune Therapy in Pediatric Severe Aplastic Anemia
Status: Enrolling
Updated: 12/31/1969
Children's Hospital of Philadelphia
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Recurrent Endometrial Cancer Clinical Trial
Pembrolizumab in Ultramutated and Hypermutated Endometrial Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Yale-New Haven Hospital
mi
from
New Haven, CT
Click here to add this to my saved trials
Unilateral Spatial Neglect (USN) Clinical Trial
The Effects of Playing Live Music in Music Therapy/Occupational Therapy Co-treatment on Unilateral Spatial Neglect
Status: Enrolling
Updated: 12/31/1969
New York University School of Medicine
mi
from
New York, NY
Click here to add this to my saved trials
HIV Clinical Trial
Dolutegravir in Reservoirs
Status: Enrolling
Updated: 12/31/1969
Grady Health System
mi
from
Atlanta, GA
Click here to add this to my saved trials
Scleroderma, Systemic Clinical Trial
Proof of Mechanism Study of GSK2330811 in Diffuse Cutaneous Systemic Sclerosis
Status: Enrolling, Phase II
Updated: 12/31/1969
GSK Investigational Site
mi
from
Baltimore, MD
Click here to add this to my saved trials
Metastatic Pancreatic Cancer Clinical Trial
RX-3117 in Combination With Abraxane® in Subjects With Metastatic Pancreatic Cancer
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Rexahn Investigative Site
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Oncology, Pulmonary / Respiratory Diseases Clinical Trial
BATTLE-2 Program - A Biomarker-Integrated Targeted Therapy in Non-Small Cell Lung Cancer (NSCLC)
Status: Enrolling, Phase I, II
Updated: 12/31/1969
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Eosinophilic Esophagitis (EoE) Clinical Trial
Continuation Study With Budesonide Oral Suspension (BOS) for Adolescent and Adult Subjects With Eosinophilic Esophagitis (EoE)
Status: Enrolling, Phase III
Updated: 12/31/1969
Connecticut Clinical Research Foundation
mi
from
Bristol, CT
Click here to add this to my saved trials
Eosinophilic Esophagitis (EoE) Clinical Trial
Continuation Study With Budesonide Oral Suspension (BOS) for Adolescent and Adult Subjects With Eosinophilic Esophagitis (EoE)
Status: Enrolling, Phase III
Updated: 12/31/1969
Arkansas Gastroenterology
mi
from
North Little Rock, AR
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
A Phase I/II Study to Evaluate the Safety of Cellular Immunotherapy Using Autologous T Cells Engineered to Express a CD20-Specific Chimeric Antigen Receptor for Patients With Relapsed or Refractory B Cell Non-Hodgkin Lymphomas
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Fred Hutch/University of Washington Cancer Consortium
mi
from
Seattle, WA
Click here to add this to my saved trials
Clinical Trial
Pembrolizumab With or Without Stereotactic Body Radiation Therapy in Treating Patients With Advanced or Metastatic Merkel Cell Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Rush - Copley Medical Center
mi
from
Aurora, IL
Click here to add this to my saved trials
Clinical Trial
Pembrolizumab With or Without Stereotactic Body Radiation Therapy in Treating Patients With Advanced or Metastatic Merkel Cell Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Ochsner Health Center-Summa
mi
from
Baton Rouge, LA
Click here to add this to my saved trials
Clinical Trial
Pembrolizumab With or Without Stereotactic Body Radiation Therapy in Treating Patients With Advanced or Metastatic Merkel Cell Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Bozeman Deaconess Hospital
mi
from
Bozeman, MT
Click here to add this to my saved trials
Clinical Trial
Pembrolizumab With or Without Stereotactic Body Radiation Therapy in Treating Patients With Advanced or Metastatic Merkel Cell Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Harrison HealthPartners Hematology and Oncology-Bremerton
mi
from
Bremerton, WA
Click here to add this to my saved trials
Clinical Trial
Pembrolizumab With or Without Stereotactic Body Radiation Therapy in Treating Patients With Advanced or Metastatic Merkel Cell Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Memorial Hospital
mi
from
Chattanooga, TN
Click here to add this to my saved trials
Clinical Trial
Pembrolizumab With or Without Stereotactic Body Radiation Therapy in Treating Patients With Advanced or Metastatic Merkel Cell Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Mount Carmel Health Center West
mi
from
Columbus, OH
Click here to add this to my saved trials
Clinical Trial
Pembrolizumab With or Without Stereotactic Body Radiation Therapy in Treating Patients With Advanced or Metastatic Merkel Cell Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Medical Oncology and Hematology Associates-Laurel
mi
from
Des Moines, IA
Click here to add this to my saved trials
Clinical Trial
Pembrolizumab With or Without Stereotactic Body Radiation Therapy in Treating Patients With Advanced or Metastatic Merkel Cell Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Carle Physician Group-Effingham
mi
from
Effingham, IL
Click here to add this to my saved trials
Clinical Trial
Pembrolizumab With or Without Stereotactic Body Radiation Therapy in Treating Patients With Advanced or Metastatic Merkel Cell Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Unity Hospital
mi
from
Fridley, MN
Click here to add this to my saved trials
Clinical Trial
Pembrolizumab With or Without Stereotactic Body Radiation Therapy in Treating Patients With Advanced or Metastatic Merkel Cell Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Great Falls Clinic
mi
from
Great Falls, MT
Click here to add this to my saved trials
Clinical Trial
Pembrolizumab With or Without Stereotactic Body Radiation Therapy in Treating Patients With Advanced or Metastatic Merkel Cell Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Sidney and Lois Eskenazi Hospital
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Clinical Trial
Pembrolizumab With or Without Stereotactic Body Radiation Therapy in Treating Patients With Advanced or Metastatic Merkel Cell Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Kalispell Regional Medical Center
mi
from
Kalispell, MT
Click here to add this to my saved trials
Clinical Trial
Pembrolizumab With or Without Stereotactic Body Radiation Therapy in Treating Patients With Advanced or Metastatic Merkel Cell Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Minimally Invasive Surgery Hospital
mi
from
Lenexa, KS
Click here to add this to my saved trials
Clinical Trial
Pembrolizumab With or Without Stereotactic Body Radiation Therapy in Treating Patients With Advanced or Metastatic Merkel Cell Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Saint Joseph Hospital East
mi
from
Lexington, KY
Click here to add this to my saved trials
Clinical Trial
Pembrolizumab With or Without Stereotactic Body Radiation Therapy in Treating Patients With Advanced or Metastatic Merkel Cell Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Minnesota Oncology Hematology PA-Maplewood
mi
from
Maplewood, MN
Click here to add this to my saved trials
Clinical Trial
Pembrolizumab With or Without Stereotactic Body Radiation Therapy in Treating Patients With Advanced or Metastatic Merkel Cell Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Saint John's Hospital - Healtheast
mi
from
Maplewood, MN
Click here to add this to my saved trials
Clinical Trial
Pembrolizumab With or Without Stereotactic Body Radiation Therapy in Treating Patients With Advanced or Metastatic Merkel Cell Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Alegent Health Bergan Mercy Medical Center
mi
from
Omaha, NE
Click here to add this to my saved trials
Clinical Trial
Pembrolizumab With or Without Stereotactic Body Radiation Therapy in Treating Patients With Advanced or Metastatic Merkel Cell Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Menorah Medical Center
mi
from
Overland Park, KS
Click here to add this to my saved trials
Clinical Trial
Pembrolizumab With or Without Stereotactic Body Radiation Therapy in Treating Patients With Advanced or Metastatic Merkel Cell Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Saint Luke's South Hospital
mi
from
Overland Park, KS
Click here to add this to my saved trials
Clinical Trial
Pembrolizumab With or Without Stereotactic Body Radiation Therapy in Treating Patients With Advanced or Metastatic Merkel Cell Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
The Mayo Clinic
mi
from
Rochester, MN
Click here to add this to my saved trials
Clinical Trial
Pembrolizumab With or Without Stereotactic Body Radiation Therapy in Treating Patients With Advanced or Metastatic Merkel Cell Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Siteman Cancer Center-South County
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Clinical Trial
Pembrolizumab With or Without Stereotactic Body Radiation Therapy in Treating Patients With Advanced or Metastatic Merkel Cell Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Park Nicollet Clinic - Saint Louis Park
mi
from
Saint Louis Park, MN
Click here to add this to my saved trials
Clinical Trial
Pembrolizumab With or Without Stereotactic Body Radiation Therapy in Treating Patients With Advanced or Metastatic Merkel Cell Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Regions Hospital
mi
from
Saint Paul, MN
Click here to add this to my saved trials
Clinical Trial
Pembrolizumab With or Without Stereotactic Body Radiation Therapy in Treating Patients With Advanced or Metastatic Merkel Cell Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
United Hospital
mi
from
Saint Paul, MN
Click here to add this to my saved trials
Clinical Trial
Pembrolizumab With or Without Stereotactic Body Radiation Therapy in Treating Patients With Advanced or Metastatic Merkel Cell Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Saint Francis Regional Medical Center
mi
from
Shakopee, MN
Click here to add this to my saved trials
Clinical Trial
Pembrolizumab With or Without Stereotactic Body Radiation Therapy in Treating Patients With Advanced or Metastatic Merkel Cell Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Mount Carmel St. Ann's
mi
from
Westerville, OH
Click here to add this to my saved trials
Lymphangioleiomyomatosis Clinical Trial
Discovery of Sirolimus Sensitive Biomarkers in Blood
Status: Enrolling, Phase
Updated: 12/31/1969
National Institutes of Health Clinical Center
mi
from
Bethesda, MD
Click here to add this to my saved trials
Nephrology / Urology, Other Clinical Trial
Prospective Research Rare Kidney Stones (ProRKS)
Status: Enrolling, Phase
Updated: 12/31/1969
Children's Memorial Hospital
mi
from
Chicago, IL
Click here to add this to my saved trials
Gastroenterology, Oncology Clinical Trial
Extracellular RNA Markers of Liver Disease and Cancer
Status: Enrolling, Phase
Updated: 12/31/1969
University of Chicago Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
JBT-101 in Systemic Lupus Erythematosus (SLE)
Status: Enrolling, Phase II
Updated: 12/31/1969
Duke University
mi
from
Durham, NC
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
JBT-101 in Systemic Lupus Erythematosus (SLE)
Status: Enrolling, Phase II
Updated: 12/31/1969
Temple University
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Depression Clinical Trial
EM/PROTECT: Improving Depression in Elder Mistreatment Victims
Status: Enrolling
Updated: 12/31/1969
Weill Cornell Medicine
mi
from
New York, NY
Click here to add this to my saved trials
Relapsing Multiple Sclerosis Clinical Trial
A Study of Immune Phenotype Biomarkers in Patients With Relapsing Multiple Sclerosis (RMS) After Treatment With 0.5mg Fingolimod
Status: Enrolling, Phase IV
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Boca Raton, FL
Click here to add this to my saved trials
Relapsing Multiple Sclerosis Clinical Trial
A Study of Immune Phenotype Biomarkers in Patients With Relapsing Multiple Sclerosis (RMS) After Treatment With 0.5mg Fingolimod
Status: Enrolling, Phase IV
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Cleveland, OH
Click here to add this to my saved trials
Relapsing Multiple Sclerosis Clinical Trial
A Study of Immune Phenotype Biomarkers in Patients With Relapsing Multiple Sclerosis (RMS) After Treatment With 0.5mg Fingolimod
Status: Enrolling, Phase IV
Updated: 12/31/1969
Novartis Investigative site
mi
from
Dallas, TX
Click here to add this to my saved trials
Relapsing Multiple Sclerosis Clinical Trial
A Study of Immune Phenotype Biomarkers in Patients With Relapsing Multiple Sclerosis (RMS) After Treatment With 0.5mg Fingolimod
Status: Enrolling, Phase IV
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Green Bay, WI
Click here to add this to my saved trials
Relapsing Multiple Sclerosis Clinical Trial
A Study of Immune Phenotype Biomarkers in Patients With Relapsing Multiple Sclerosis (RMS) After Treatment With 0.5mg Fingolimod
Status: Enrolling, Phase IV
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Greer, SC
Click here to add this to my saved trials
Relapsing Multiple Sclerosis Clinical Trial
A Study of Immune Phenotype Biomarkers in Patients With Relapsing Multiple Sclerosis (RMS) After Treatment With 0.5mg Fingolimod
Status: Enrolling, Phase IV
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Hartford, CT
Click here to add this to my saved trials
Relapsing Multiple Sclerosis Clinical Trial
A Study of Immune Phenotype Biomarkers in Patients With Relapsing Multiple Sclerosis (RMS) After Treatment With 0.5mg Fingolimod
Status: Enrolling, Phase IV
Updated: 12/31/1969
Novartis Investigator Site
mi
from
Kirkland, WA
Click here to add this to my saved trials
Relapsing Multiple Sclerosis Clinical Trial
A Study of Immune Phenotype Biomarkers in Patients With Relapsing Multiple Sclerosis (RMS) After Treatment With 0.5mg Fingolimod
Status: Enrolling, Phase IV
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Knoxville, TN
Click here to add this to my saved trials
Relapsing Multiple Sclerosis Clinical Trial
A Study of Immune Phenotype Biomarkers in Patients With Relapsing Multiple Sclerosis (RMS) After Treatment With 0.5mg Fingolimod
Status: Enrolling, Phase IV
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Patchogue, NY
Click here to add this to my saved trials
Relapsing Multiple Sclerosis Clinical Trial
A Study of Immune Phenotype Biomarkers in Patients With Relapsing Multiple Sclerosis (RMS) After Treatment With 0.5mg Fingolimod
Status: Enrolling, Phase IV
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Plainview, NY
Click here to add this to my saved trials
Relapsing Multiple Sclerosis Clinical Trial
A Study of Immune Phenotype Biomarkers in Patients With Relapsing Multiple Sclerosis (RMS) After Treatment With 0.5mg Fingolimod
Status: Enrolling, Phase IV
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Port Charlotte, FL
Click here to add this to my saved trials
Relapsing Multiple Sclerosis Clinical Trial
A Study of Immune Phenotype Biomarkers in Patients With Relapsing Multiple Sclerosis (RMS) After Treatment With 0.5mg Fingolimod
Status: Enrolling, Phase IV
Updated: 12/31/1969
Novartis
mi
from
San Antonio, TX
Click here to add this to my saved trials
Relapsing Multiple Sclerosis Clinical Trial
A Study of Immune Phenotype Biomarkers in Patients With Relapsing Multiple Sclerosis (RMS) After Treatment With 0.5mg Fingolimod
Status: Enrolling, Phase IV
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Savannah, GA
Click here to add this to my saved trials
Relapsing Multiple Sclerosis Clinical Trial
A Study of Immune Phenotype Biomarkers in Patients With Relapsing Multiple Sclerosis (RMS) After Treatment With 0.5mg Fingolimod
Status: Enrolling, Phase IV
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Tacoma, WA
Click here to add this to my saved trials
Relapsing Multiple Sclerosis Clinical Trial
A Study of Immune Phenotype Biomarkers in Patients With Relapsing Multiple Sclerosis (RMS) After Treatment With 0.5mg Fingolimod
Status: Enrolling, Phase IV
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Vienna, VA
Click here to add this to my saved trials
Diffuse Large B-Cell Lymphoma Clinical Trial
A Study Comparing the Efficacy and Safety of Polatuzumab Vedotin With Rituximab-Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab-Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Diffuse Large B-Cell Lymphoma
Status: Enrolling, Phase III
Updated: 12/31/1969
Medical University of South Carolina Hospital
mi
from
Charleston, SC
Click here to add this to my saved trials
Diffuse Large B-Cell Lymphoma Clinical Trial
A Study Comparing the Efficacy and Safety of Polatuzumab Vedotin With Rituximab-Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab-Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Diffuse Large B-Cell Lymphoma
Status: Enrolling, Phase III
Updated: 12/31/1969
Memorial Sloan-Kettering Cancer Center at Commack
mi
from
Commack, NY
Click here to add this to my saved trials
Diffuse Large B-Cell Lymphoma Clinical Trial
A Study Comparing the Efficacy and Safety of Polatuzumab Vedotin With Rituximab-Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab-Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Diffuse Large B-Cell Lymphoma
Status: Enrolling, Phase III
Updated: 12/31/1969
Southern Cancer Center, PC
mi
from
Daphne, AL
Click here to add this to my saved trials
Diffuse Large B-Cell Lymphoma Clinical Trial
A Study Comparing the Efficacy and Safety of Polatuzumab Vedotin With Rituximab-Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab-Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Diffuse Large B-Cell Lymphoma
Status: Enrolling, Phase III
Updated: 12/31/1969
Florida Cancer Specialists and Research Institute
mi
from
Saint Petersburg, FL
Click here to add this to my saved trials
Diffuse Large B-Cell Lymphoma Clinical Trial
A Study Comparing the Efficacy and Safety of Polatuzumab Vedotin With Rituximab-Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab-Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Diffuse Large B-Cell Lymphoma
Status: Enrolling, Phase III
Updated: 12/31/1969
University of Utah (Huntsman Cancer Hospital)
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Myasthenia Gravis, Generalized Clinical Trial
Study to Evaluate Amifampridine Phosphate in Patients With MuSK-MG
Status: Enrolling, Phase III
Updated: 12/31/1969
University of Southern California
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Myasthenia Gravis, Generalized Clinical Trial
Study to Evaluate Amifampridine Phosphate in Patients With MuSK-MG
Status: Enrolling, Phase III
Updated: 12/31/1969
Rush University
mi
from
Chicago, IL
Click here to add this to my saved trials
Myasthenia Gravis, Generalized Clinical Trial
Study to Evaluate Amifampridine Phosphate in Patients With MuSK-MG
Status: Enrolling, Phase III
Updated: 12/31/1969
Michigan State University
mi
from
East Lansing, MI
Click here to add this to my saved trials
Myasthenia Gravis, Generalized Clinical Trial
Study to Evaluate Amifampridine Phosphate in Patients With MuSK-MG
Status: Enrolling, Phase III
Updated: 12/31/1969
Houston Methodist
mi
from
Houston, TX
Click here to add this to my saved trials
Myasthenia Gravis, Generalized Clinical Trial
Study to Evaluate Amifampridine Phosphate in Patients With MuSK-MG
Status: Enrolling, Phase III
Updated: 12/31/1969
UC, Irvine
mi
from
Irvine, CA
Click here to add this to my saved trials
Myasthenia Gravis, Generalized Clinical Trial
Study to Evaluate Amifampridine Phosphate in Patients With MuSK-MG
Status: Enrolling, Phase III
Updated: 12/31/1969
Wesley Neurology Clinic
mi
from
Memphis, TN
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Pediatric Hypertension Registry (PHREG)
Status: Enrolling, Phase
Updated: 12/31/1969
Wake Forest University Baptist Medical Center
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Rare Kidney Stone Diseases Clinical Trial
Monogenic Kidney Stone - Genetic Testing
Status: Enrolling, Phase
Updated: 3/21/2018
The Mayo Clinic
mi
from
Rochester, MN
Click here to add this to my saved trials
Contrast-Induced Nephropathy Clinical Trial
Automated Prediction and Prevention of Contrast Induced Nephropathy After Cardiac Catheterization
Status: Enrolling, Phase
Updated: 3/14/2018
University of Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
Cochlear Implant Clinical Trial
Image-guided Cochlear Implant Programming (IGCIP)
Status: Enrolling
Updated: 12/31/1969
Vanderbilt University Medical Center
mi
from
Nashville, TN
Click here to add this to my saved trials
Substance-Related Disorders Clinical Trial
COMET Study 1: Filter Ventilated Cigarette Substitution in the ETM
Status: Enrolling
Updated: 12/31/1969
Virginia Tech Carilion Research Institute
mi
from
Roanoke, VA
Click here to add this to my saved trials
Spinal Deformity Clinical Trial
Prospective, Multi-Center Adult Spinal Deformity Outcomes Database Registry
Status: Enrolling
Updated: 10/10/2017
Scripps Clinic
mi
from
La Jolla, CA
Click here to add this to my saved trials
Spinal Deformity Clinical Trial
Prospective, Multi-Center Adult Spinal Deformity Outcomes Database Registry
Status: Enrolling
Updated: 10/10/2017
University of California, San Francisco Medical Center
mi
from
San Francisco, CA
Click here to add this to my saved trials
Relapsing Multiple Scelrosis Clinical Trial
Efficacy and Safety of Ofatumumab Compared to Teriflunomide in Patients With Relapsing Multiple Sclerosis.
Status: Enrolling, Phase III
Updated: 12/31/1969
Novartis
mi
from
Baltimore, MD
Click here to add this to my saved trials
Relapsing Multiple Scelrosis Clinical Trial
Efficacy and Safety of Ofatumumab Compared to Teriflunomide in Patients With Relapsing Multiple Sclerosis.
Status: Enrolling, Phase III
Updated: 12/31/1969
Novartis Investigator Site
mi
from
Birmingham, AL
Click here to add this to my saved trials
Relapsing Multiple Scelrosis Clinical Trial
Efficacy and Safety of Ofatumumab Compared to Teriflunomide in Patients With Relapsing Multiple Sclerosis.
Status: Enrolling, Phase III
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Bradenton, FL
Click here to add this to my saved trials
Relapsing Multiple Scelrosis Clinical Trial
Efficacy and Safety of Ofatumumab Compared to Teriflunomide in Patients With Relapsing Multiple Sclerosis.
Status: Enrolling, Phase III
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Centennial, CO
Click here to add this to my saved trials
Relapsing Multiple Scelrosis Clinical Trial
Efficacy and Safety of Ofatumumab Compared to Teriflunomide in Patients With Relapsing Multiple Sclerosis.
Status: Enrolling, Phase III
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Colorado Springs, CO
Click here to add this to my saved trials
Relapsing Multiple Scelrosis Clinical Trial
Efficacy and Safety of Ofatumumab Compared to Teriflunomide in Patients With Relapsing Multiple Sclerosis.
Status: Enrolling, Phase III
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Columbus, GA
Click here to add this to my saved trials